Literature DB >> 1863618

[Epidemic outbreak of methicillin-resistant Staphylococcus aureus in a general hospital. Preliminary report].

F Parras1, M Rodríguez, E Bouza, P Muñoz, E Cercenado, C Guerrero, G Zancada.   

Abstract

The incidence of MRSA infections in Spain had remained in a low level through the years, being MRSA usually less than 1.5% of all S. aureus isolates. Since October 1988, we have detected in our hospital a MRSA outbreak. The epidemic started in the surgical wards, and spread through the rest of the institution. The incidence of cases was higher in the ICU's, areas that act as "multipliers" of the outbreak. In spite of standard control measures, the total number of patients with MRSA was 245 in April 1990. We studied prospectively a sample of 100 MRSA patients: thirty-six percent were colonized and 46% infected. The more common source of infection was the lower respiratory tract and primary bacteremia. The infection-related mortality was 30%. Our MRSA strain belong to phage type III, and shows a characteristic multiple antibiotic resistant pattern, the MRSA strain is sensitive to vancomycin, fusidic acid, phosphomycin and cotrimoxazole. Over the entire outbreak period, the MRSA strain developed resistance to rifampin, imipenem-cilastatin and ciprofloxacin. In spite of all control measures implemented, the outbreak can not have been totally controlled, and MRSA is now an endemic pathogen in our institution. Therefore, major changes in therapeutic approach to nosocomial infections have been since then introduced.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1863618

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


  6 in total

1.  Methicillin-resistant Staphylococcus aureus in Europe.

Authors:  A Voss; D Milatovic; C Wallrauch-Schwarz; V T Rosdahl; I Braveny
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-01       Impact factor: 3.267

2.  Risk factors for nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus.

Authors:  M Pujol; C Peña; R Pallares; J Ayats; J Ariza; F Gudiol
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-01       Impact factor: 3.267

3.  Prospective study of infection, colonization and carriage of methicillin-resistant Staphylococcus aureus in an outbreak affecting 990 patients.

Authors:  R Coello; J Jiménez; M García; P Arroyo; D Minguez; C Fernández; F Cruzet; C Gaspar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-01       Impact factor: 3.267

4.  Comparative study of mupirocin and oral co-trimoxazole plus topical fusidic acid in eradication of nasal carriage of methicillin-resistant Staphylococcus aureus.

Authors:  F Parras; M C Guerrero; E Bouza; M J Blázquez; S Moreno; M C Menarguez; E Cercenado
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

5.  Hospital infections in Spain. I. Staphylococcus aureus (1978-91).

Authors:  A Vindel; P Trincado; M M Martín de Nicolás; E Gómez; C Martín Bourgon; J A Sáez Nieto
Journal:  Epidemiol Infect       Date:  1993-06       Impact factor: 2.451

6.  Methicillin Resistant Staphylococcus aureus among HIV Infected Pediatric Patients in Northwest Ethiopia: Carriage Rates and Antibiotic Co-Resistance Profiles.

Authors:  Martha Tibebu Lemma; Yohannes Zenebe; Begna Tulu; Daniel Mekonnen; Zewdie Mekonnen
Journal:  PLoS One       Date:  2015-09-30       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.